[1] 克劳迪娅•S.科恩,等编.AABB技术手册[M].桂嵘,陈秉宇,黄远帅,王勇军,译.第20版.长沙:中南大学出版社,2022. [2] 杨成民,刘进,赵桐茂.中华输血学[M].第2版.北京:人民卫生出版社,2022.668-674. [3] 李丹,刘湘巧,陈明军,等.4种抗体筛选细胞与谱细胞的试剂比对及不规则抗体筛查现状分析[J].中国卫生检验杂志,2020,30(10):1196-1199. [4] 闫烨. 输血患者排除抗筛假阴性的意义探讨[J].中华全科医学,2023,21(10):1732-1735. [5] 陈春霞,魏曾珍,谭金哲,等.国内抗体筛查细胞试剂比对[J].中国输血杂志,2017,30(11):1243-1245. [6] 王谦,燕备战,于洋.31766名患者红细胞血型不规则抗体分析[J].中国输血杂志,2011,24(11):966-968. [7] 曹微微,舒象武,李碧娟,等.55481例住院拟输血患者红细胞血型不规则抗体分析[J].临床输血与检验,2013,15(3):238-240. [8] WANG Q S,YANG Q N,BAI Y Z,et al.Frequency of RBC alloantibodies in Chinese surgical patients[J].Transfus Med Hemother,2012,39(4):283-286. [9] POLITOU M,VALSAMI S,DRYLLIS G,et al.Retrospective study on prevalence,specificity,sex,and age distribution of alloimmunization in two general hospitals in Athens[J].Turk J Haematol,2020,37(3):154-166. [10] EVERS D,MIDDELBURG R A,DE HAAS M,et al.Red-blood-cell alloimmunisation in relation to antigens' exposure and their immunogenicity:a cohort study[J].Lancet Haematol,2016,3(6):e284-e292. [11] SPANOS T,KARAGEORGA M,LADIS V,et al.Red cell alloantibodies in patients with thalasseMia[J].Vox Sang,1990,58(1):50-55. [12] WINTERS J L,PINEDA A A,GORDEN L D,et al.RBC alloantibody specificity and antigen potency in Olmsted County,Minnesota[J].Transfusion,2001,41(11):1413-1420. [13] CHEN C X,TAN J Z,WANG L X,et al.Unexpected red blood cell antibody distributions in Chinese people by a systematic literature review[J].Transfusion,2016,56(4):975-979. [14] MO Z,LI H,HUANG L,et al.Prevalence and specificity of RBC alloantibodies in the general hospitalised population in Guangxi[J].Transfus Med,2015,25(5):313-319. [15] 杨晓华,李玉秋,张慧娴,等.Rh和MNS血型系统临床输血患者不规则抗体的分布特点及意义[J].河北医药,2022,44(3):453-455. [16] 陈碧乐,蔡雪娇,叶银才,等.住院患者红细胞血型不规则抗体特点调查[J].温州医科大学学报,2020,50(11):915-918. [17] AMEEN R,AL-EYAADI O,AL-SHEMMARI S,et al.Frequency of red blood cell alloantibody in Kuwaiti population[J].Med Princ Pract,2005,14(4):230-234. [18] AZARKEIVAN A,AHMADI M H,ZOLFAGHARI S,et al.RBC alloimmunization and double alloantibodies in thalassemic patients[J].Hematology,2015,20(4):223-227. [19] 许亚莉,吴继博,徐华,等.多中心联合筛查红细胞血型不规则抗体的大数据分析[J].中国输血杂志,2018,31(8):823-825. [20] 张保萍,张嵘,王文婷,等.谱细胞鉴定剂量效应分析偏差致抗-C抗体漏检1例[J].临床输血与检验,2021,23(2):236-239. [21] 郭淦平,吴树杰,温妙珍,等.国内常用抗体筛选试剂红细胞抗原谱分析[J].中国输血杂志,2020,33(8):761-764. [22] 孙晓琳,于洋,关晓珍,等.“剂量效应” 现象对意外抗体鉴定的影响[J].中国实验血液学杂志,2015,23(1):222-227. [23] 王颖,许志远,庄光艳,等.剂量效应对抗体鉴定的影响[J].北京医学,2019,41(5):411-413. [24] 陈荣华,冯文斌,周清,等.国内外抗体鉴定谱细胞抗原谱质量对比分析[J].临床输血与检验,2021,23(5):617-622. [25] TORMEY C A,STACK G.Immunogenicity of blood group antigens:a mathematical model corrected for antibody evanescence with exclusion of naturally occurring and pregnancy-related antibodies[J].Blood,2009,114(19):4279-4282. [26] STACK G,TORMEY C A.Estimating the immunogenicity of blood group antigens:a modified calculation that corrects for transfusion exposures[J].Br J Haematol,2016,175(1):154-160. [27] 李菲,施丽,朱蓉,等.新疆地区Kell(K)血型及Rh(D)血型抗原及基因频率调查[J].中国实验血液学杂志,2023,31(6):1825-1830. [28] 邱进,陈伟,李菲,等.新疆地区维吾尔族人群Rh、Kell血型抗原分布频率调查及Kell阳性个体分子机制研究[J].中国输血杂志,2022,8(10):1009-1013. [29] 范方志,刘文超,隋佳,等.20354名青岛地区人群K抗原血清学筛选结果[J].中国输血杂志,2023,36(11):1061-1064. [30] 包于勤,丁苏鄂,谢云峥,等.10057例上海地区献血者K抗原频率的调查[J].临床输血与检验,2003,5(3):203-204. [31] 李翠莹,徐弘,黄菲,等.四川汉族人群Mur抗原频率调查[J].临床血液学杂志,2015,28(12):1078-1079. [32] 朱自严,沈伟,陈和平,等.上海地区部分人群Jk(a-b-)、Dib-、Wrb-、K0、Ena-、Tja-、Ge-稀有血型筛选[J].中国输血杂志,2002,15(4):232-233. [33] 严康峰,邓诗桢,曾玫玫,等.广州番禺地区献血人群稀有血型的筛选[J].中国输血杂志,2007,20(4):290-291. [34] 孙爱农,孙雯婷,李勇.Miltenberger血型系列和Mur(MNS10)血型抗原及其临床意义[J].中国输血杂志,2010,23(5):403-406. [35] LI Q,DUAN S B,SUN A N,et al.Study on the antigens and antibodies of Mur and Mia blood groups in Southern China[J].Transfus Apher Sci,2022,61(4):103378. [36] 王荣鹏,郑洋洋,陈凤.内蒙古地区蒙古族人群多种红细胞血型系统基因的多态性研究[J].中国输血杂志,2021,34(12):1305-1309. [37] 牟秋菊,范亮峰,王学锋,等.一例抗-Dia合并抗-Wra的疑难标本鉴定及基因分型检测[J].中国输血杂志,2023,36(2):195-198. [38] 温机智,付涌水,罗广平,等.广州地区汉族人群Diego血型系统多态性调查[J].中国输血杂志,2015,28(6):663-665. [39] 李晓丰,车宝轩,张坤莲,等.辽宁地区汉族献血人群Diego血型基因频率调查及稀有血型库的建立[J].中国输血杂志,2019,32(9):851-854. [40] TING J Y,MA E S K,WONG K Y.A case of severe haemolytic disease of the newborn due to anti-Di(a) antibody[J].Hong Kong Med J,2004,10(5):347-349. [41] MARION E.REID CL,MARTIN LO.The Blood Group Antigen FactsBook[M].Third Editioned :Academic Press in an imprint of Elsevier,2012.388. [42] HOLMAN C A.A new rare human bloodgroup antigen (Wra)[J].Lancet,1953,265(6777):119-120. [43] CLEGHORN T E.The frequency of the Wr-a,By and Mg blood group antigens in blood donors in the south of England[J].Vox Sang,1960,5:556-560. [44] ARRIAGA F,LLOPIS F,DE LA RUBIA J,et al.Incidence of Wra antigen and anti-Wra in a Spanish population[J].Transfusion,2005,45(8):1324-1326. [45] 褚晓月,左琴琴,毛娟,等.陕西地区无偿献血者Wra抗原分布多态性及其抗体频率调查——附临床抗-Wra鉴定2例[J].中国输血杂志,2021,34(1):52-54. [46] SCHONEWILLE H,VAN ZIJL A M,WIJERMANS P W.The importance of antibodies against low-incidence RBC antigens in complete and abbreviated cross-matching[J].Transfusion,2003,43(7):939-944. [47] YU Y,MA C,SUN X,et al.Frequencies of red blood cell major blood group antigens and phenotypes in the Chinese Han population from Mainland China[J].Int J Immunogenet,2016,43(4):226-235. [48] MUSA R H,AHMED S A,HASHIM H,et al.Red cell phenotyping of blood from donors at the National blood center of Malaysia[J].Asian J Transfus Sci,2012,6(1):3-9. [49] 谭兵,陈瑶,余泽波,等.重庆地区157927例住院患者Rh血型表型分布调查[J].第三军医大学学报,2020,42(16):1670-1675. [50] 孙昂,苏湘晖,陈宏伟,等.岳阳汉族人群10个红细胞血型系统基因频率及多态性研究[J].中国输血杂志,2020,33(10):1033-1037. [51] 刘颖,毕冬梅,赵素珍,等.中国哈尔滨地区满族人群11个红细胞血型系统24种稀有血型抗原的基因多态性研究[J].中国实验血液学杂志,2017,25(6):1799-1803. [52] 陈婉璐,张婵,李琦,等.云南傣族人群红细胞Rh、Duffy血型抗原多态性调查[J].临床输血与检验,2017,19(5):487-490. [53] BRITISH Committee for Standards in Haematology,MILKINS C,BERRYMAN J,et al.Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories.British Committee for Standards in Haematology[J].Transfus Med,2013,23(1):3-35. [54] Australian and New Zealand Society of Blood Transfusion[M].1st Editioned :Australian & New Zealand Society of Blood Transfusion Ltd,2016. [55] 奥田誠,池本純子,石丸健,等.赤血球型検査(赤血球系検査)ガイドライン(改訂4版)[J].日本輸血細胞治療学会誌,2022,68(6):539-556. [56] RAMAN L,ARMSTRONG B,SMART E.Principles of laboratory techniques[J].ISBT Sci Ser,2020,15(S1):81-111. [57] 国家卫生健康委员会.输血相容性检测标准[S].2022. [58] 桂嵘,张志昇,王勇军.输血相容性检测及疑难病例分析[M].第1版.北京:人民卫生出版社,2018. [59] LOREN A,CHARMAN D,JABS D,et al.Determination of homozygote vs heterozygote of blood group antigens with protein A[J].Kurume Med J,1980,27(2):71-77. [60] OIEN L,NANCE S,ARNDT P,et al.Determination of zygosity using flow cytometric analysis of red cell antigen strength[J].Transfusion,1988,28(6):541-544. [61] 崔颖,张勇萍,杨世明,等.不规则抗体筛选与特异性鉴定的影响因素及其对策分析[J].细胞与分子免疫学杂志,2022,38(2):165-170. [62] FISHER R A.Statistical methods and scientific inference[M].2nded.Oliver and Boyd, 1956. [63] HARRIS R E,HOCHMAN H G.Revised P values in testing blood group antibodies.Fisher’s exact test revisited[J].Transfusion,1986,26(6):494-499. [64] KANTER M H,POOLE G,GARRATTY G.Misint-erpretation and misapplication of p values in antibody identification:the lack of value of a p value[J].Transfusion,1997,37(8):816-822. [65] 李喜莹,蔡鹃,甘佳,等.红细胞血型抗体鉴定专家共识[J].中国输血杂志,2021,34(10):1061-1065. [66] 李小飞,郎嵘,刁雪芹,等.筛选细胞组合法预测红细胞同种抗体的临床应用[J].中国实验血液学杂志,2021,29(4):1325-1329. [67] LI X.Several screening cells combination could predict red blood cell alloantibody?[J].Transfus Clin Biol,2022,29(3):276-278. |